# Sonio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sonio

- Industry: Software
- Headquarters: Paris, France
- Website: www.sonio.ai
- Total disclosed funding: $18M
- Latest round: Series A (Jul 11, 2023)
- Investors on record: 4

## About

Based in France, and founded in 2020, Sonio operates as a medical software company. The company was founded by its CEO Cecile Brosset, and CSO Remi Besson. In July 2023, Sonio raised EUR 13 million in series A funding co-led by Cross-Border Impact Ventures and Elaia Partners, with participation from OneRagtime. Individual investors also participated in the round.

Sonio product line includes Sonio Diagnostics, which is artificial intelligence software built on a SaaS platform to assist in the diagnosis of fetal anomalies and associated syndromes; Sonio Screening, which is a medical software used for prenatal screening and fetal ultrasound.

The company plans to use the funds raised in July 2023 to expand its market reach in the US and develop its technological and commercial growth.

## Funding rounds

- Series A, Jul 11, 2023, $15M — Elaia Partners, Bpifrance, OneRagtime, Cross-Border Impact Ventures
- Seed, Sep 19, 2022, $3.3M — Elaia Partners, Bpifrance, OneRagtime

## Investors

- Elaia Partners (https://capitalatlas.ai/funds/elaia-partners) — Seed, Series A
- Bpifrance — Seed, Series A
- OneRagtime (https://capitalatlas.ai/funds/oneragtime) — Seed, Series A
- Cross-Border Impact Ventures (https://capitalatlas.ai/funds/cross-border-impact-ventures) — Series A